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Summary
IB kinase  (IKK), required for NF-B activation,
links chronic inflammation with carcinogenesis. We
investigated whether IKK is involved in chemically
induced liver cancer, a model not involving overt in-
flammation. Surprisingly, mice lacking IKK only in
hepatocytes (IkkbDhep mice) exhibited a marked in-
crease in hepatocarcinogenesis caused by diethylni-
trosamine (DEN). This correlated with enhanced re-
active oxygen species (ROS) production, increased
JNK activation, and hepatocyte death, giving rise to
augmented compensatory proliferation of surviving he-
patocytes. Brief oral administration of an antioxidant
around the time of DEN exposure blocked prolonged
JNK activation and compensatory proliferation and
prevented excessive DEN-induced carcinogenesis in
IkkbDhep mice. Decreased hepatocarcinogenesis was
also found in mice lacking IKK in both hepatocytes
and hematopoietic-derived Kupffer cells. These mice
exhibited reduced hepatocyte regeneration and di-
minished induction of hepatomitogens, which were
unaltered in IkkbDhep mice. IKK, therefore, orches-
trates inflammatory crosstalk between hepatocytes
and hematopoietic-derived cells that promotes chem-
ical hepatocarcinogenesis.
Introduction
Carcinogenesis involves alterations such as insensitiv-
ity to growth inhibition, evasion of apoptosis, immortali-
zation, angiogenesis, and metastasis (Hanahan and
Weinberg, 2000). Some of these alterations are genetic
and provided by activation of protooncogenes or inacti-
vation of tumor suppressors. However, other alterations
involve epigenetic events and environmental factors
extrinsic to the cancer cell. Early on, a major insight
to cancer etiology was provided by the realization that
carcinogenesis occurs through sequential stages
termed initiation, promotion, and progression (Beren-
blum, 1954). These stages were characterized in model
systems as well as human neoplasms (Klein and Klein,
1985). Whereas tumor initiation depends on somatic
mutations, the mechanisms underlying tumor promo-
tion are poorly understood and likely to involve epige-
netic factors. For instance, in liver cancer, different*Correspondence: karinoffice@ucsd.edusubstances that trigger either cell death, chronic inflam-
mation, or peroxisome proliferation all act as tumor pro-
moters (Sarma et al., 1986). One common tumor-pro-
moting mechanism may involve inflammation (Philip et
al., 2004). However, it was estimated that inflammation
may play a role in the etiology of only 15% of human
cancers, mostly acting as a tumor promoter (Coussens
and Werb, 2002).
A major link between inflammation and carcinogene-
sis may depend on NF-κB transcription factors, critical
regulators of innate immune responses and inflamma-
tion (Karin et al., 2002). Many proinflammatory stimuli
activate NF-κB, mostly through IκB kinase (IKK)-depen-
dent phosphorylation and degradation of inhibitor of κB
(IκB) proteins. Once activated, NF-κB dimers stimulate
transcription of genes encoding cytokines, growth fac-
tors, chemokines, and antiapoptotic factors (Ghosh
and Karin, 2002). IKK consists of two catalytic subunits,
IKKα and IKKβ, and a regulatory component, IKKγ/
NEMO. IKK and NF-κB activation by most stimuli
largely depends on IKKβ (Ghosh and Karin, 2002),
whose absence increases susceptibility to tumor ne-
crosis factor α (TNFα)-induced apoptosis and causes
loss of innate immunity (Li et al., 1999). NF-κB was
shown to be instrumental for tumor promotion in a coli-
tis-associated cancer (CAC) model (Greten et al., 2004)
and inflammation-associated liver cancer (Pikarsky et
al., 2004). Yet, inhibition of NF-κB in keratinocytes pro-
motes squamous cell carcinoma (Dajee et al., 2003).
Such results suggest that the impact of NF-κB on can-
cer development may be cell type or model specific. It
is likely that NF-κB activation is most critical in those
cancers in which inflammation acts as a tumor pro-
moter, but a more general role for NF-κB and the inflam-
mation driven by it, in cancers that are not associated
with chronic inflammation, remains to be established.
Hepatocellular carcinoma (HCC) is the third largest
cause of cancer deaths worldwide, particularly in Africa
and Asia. Major HCC risk factors include dietary expo-
sure to the fungal contaminant aflatoxin B1 (AFB1), in-
fection with hepatitis B (HBV) or C viruses (HCV), and
cirrhosis associated with chronic inflammation. Addi-
tional risk factors are environmental pollutants, such as
aromatic amines, vinyl chloride, polycyclic aromatic hy-
drocarbons, and nitrosamines (Bosch et al., 2004).
However, the causal and mechanistic relationships be-
tween HCC risk factors and carcinogenic mechanisms
have been difficult to elucidate in either humans (Thor-
geirsson and Grisham, 2002) or in animal models (Sell
and Leffert, 1982).
Studies with genetically altered mice have revealed
many genes associated with HCC. Such genes fall into
two categories: those that augment spontaneous HCC
and those that increase susceptibility to chemically in-
duced HCC. HCC develops spontaneously in trans-
genic mice overexpressing HBV surface antigen (HBsAg),
the hepatomitogen transforming growth factor α (TGFα),
the c-Myc protooncogene, or SV40 T antigen (Fausto,
1999). HCC development is also augmented in mice de-
ficient in type II TGFβ receptor (Im et al., 2001) or the
Cell
978Mdr2 P-glycoprotein transporter (Mauad et al., 1994). b
oMost of these mouse strains display enhanced suscep-
tibility to chemical carcinogens, yet the underlying mo- o
alecular and cellular mechanisms are not well under-
stood. w
oCertain chemical carcinogens are efficient inducers
of HCC. A single postnatal injection of the tumor initia- t
ator diethylnitrosamine (DEN), which induces hepatocyte
DNA damage, can result in HCC, whose course of de- a
tvelopment is similar to human HCC (Verna et al., 1996).
In very young mice, DEN is a complete carcinogen, but t
awhen given to older mice it requires assistance from
tumor promoters, acting through diverse mechanisms a
m(Sarma et al., 1986). As the ability of DEN to form DNA
adducts should not be age dependent (Dyroff et al., H
t1986), it is not clear why it is so effective as a single
agent in neonates but not in adults. Recently, it was o
ishown that a hepatocyte-specific deletion of either the
c-Jun or the Foxm1b genes, which encode transcrip- h
Ition factors needed for hepatocyte proliferation, inhibit
DEN-induced hepatocarcinogenesis (Eferl et al., 2003; a
IKalinichenko et al., 2004). Thus, hepatocyte prolifera-
tion is required for DEN-induced carcinogenesis.
iTo determine whether inflammation and NF-κB acti-
vation in hepatocytes are involved in chemical hepato- (
ocarcinogenesis, we used the DEN-induced HCC model.
Surprisingly, hepatocyte-specific deletion of IKKβ, i
uwhich prevents NF-κB activation (Maeda et al., 2003),
markedly increased DEN-induced hepatocarcinogen-
iesis. IKKβ deletion also augmented hepatocyte death
mediated by enhanced ROS production and prolonged p
fJNK activation (Kamata et al., 2005). This death re-
sponse was accompanied by augmented compensa- j
mtory proliferation. A deletion of IKKβ in both hepato-
cytes and hematopoietic-derived cells, however, had f
lthe opposite effect, decreasing compensatory prolifer-
ation and carcinogenesis. The death of DEN-exposed m
(hepatocytes was found to activate adjacent myeloid
cells (Kupffer cells) to produce hepatomitogens that
tpromote compensatory proliferation of surviving hepa-
tocytes. Production of these mitogens depends on m
cNF-κB in hematopoietic-derived Kupffer cells. These
results, which differ from a previous suggestion that the e
tumor-promoting function of NF-κB is excreted in hepa-
tocytes (Pikarsky et al., 2004), indicate that even chemi- I
cal carcinogenesis depends on inflammation and raise G
the prospect of anti-inflammatory intervention targeting t
Kupffer cells in chemoprevention of HCC. Our results d
also suggest that chemicals or viruses that interfere n
with NF-κB activation in hepatocytes may promote m
HCC development. a
s
cResults
t
oIkkbDhep Mice Exhibit Increased Susceptibility to
Chemical Hepatocarcinogenesis e
cA single DEN injection to 15-day-old male mice results
in efficient HCC induction (Sarma et al., 1986). To deter- i
Nmine the role of IKKβ in this process, male mice homo-
zygous for either a floxed Ikkb allele (IkkbF/F) or an he- (
opatocyte-specific deletion thereof (IkkbDhep) (Maeda et
al., 2003) were injected with DEN (5 mg/kg) on day 15 a
Lpostnatally when IKKβ was absent from hepatocytesut present in nonparenchymal cells (Figure 1A). Previ-
us studies revealed no spontaneous liver dysfunction
r HCC in IkkbDhep mice for up to 2 years (Maeda et
l., 2003). All males given DEN developed typical HCCs
ithin 8 months (Figures 1B–1E). Strikingly, the number
f detectable HCCs was 3-fold higher in IkkbDhep mice
han in IkkbF/F controls (Figure 1F). The tumor-occupied
rea was also 3-fold larger in IkkbDhep mice (Figure 1G),
nd so were maximal tumor diameters (Figure 1H). No-
ably, many HCCs in IkkbDhep mice, but none in the con-
rols, exhibited signs of neovascularization (Figures 1C
nd 1E, see Figure S1 in the Supplemental Data avail-
ble with this article online). Congruently, some IkkbDhep
ice but none of the IkkbF/F controls had human-like
CC metastases (random cord structure, liver plates
wo to four cells thick) in their lungs (Figures 1I and 1J)
r peritoneal cavity (data not shown) at 8 months. DEN-
njected IkkbDhep mice also exhibited significantly
igher and accelerated mortality than similarly treated
kkbF/F mice (Figure 1K). A high dose (25 mg/kg) of DEN
lso induced higher HCC load in IkkbDhep mice than
kkbF/F controls (Figure S2A).
Female mice are less sensitive than males to DEN-
nduced carcinogenesis due to hormonal factors
Sarma et al., 1986). As expected, HCCs were observed
nly in 10% of DEN-treated IkkbF/F females, but tumor
ncidence was 4-fold higher in IkkbDhep females (Fig-
re 1L).
In older mice, DEN is a less potent carcinogen, and
t requires assistance from tumor promoters such as
henobarbital (Sarma et al., 1986). To examine the ef-
ect of IKKβ on this initiation-promotion model, we in-
ected 4-week-old mice with 100 mg/kg DEN and ad-
inistered 0.07% phenobarbital in the drinking water
or 6 months starting 1 month after DEN injection. This
ed to HCCs in 55% of IkkbF/F mice and 100% of IkkbDhep
ice. Tumor number was also higher in IkkbDhep mice
Figure S2B).
Hence, loss of IKKβ in hepatocytes increases suscep-
ibility to DEN-induced carcinogenesis. This stands in
arked contrast to IKKβ ablation in intestinal epithelial
ells, which prevents chemically induced CAC (Greten
t al., 2004).
kkbDhep Tumors Retain IKK Deficiency
iven these surprising findings, we wished to confirm
hat HCCs in IkkbDhep mice are IKKβ deficient. Fine-nee-
le biopsies of control nontreated liver, DEN-exposed
ormal liver, and tumor nodules were analyzed by im-
unoblotting. IKKβ was present in IkkbF/F nontumor
nd tumor samples but barely detectable in IkkbDhep
amples (Figure 2A). Since isolated IkkbDhep hepato-
ytes do not express IKKβ (Maeda et al., 2003), the
race amounts of IKKβ in IkkbDhep samples probably
riginated from nonparenchymal cell types, all of which
xpress IKKβ. Consistently, IKKβ was absent in isolated
ancer cells (Figure 2B). Presence of two IkkbD alleles
n IkkbDhep tumors was confirmed by PCR (Figure 2C).
o significant changes in expression of IKKα, RelA
p65), cRel, RelB, or IκBα were found (Figure 2A). Levels
f NF-κB binding activity in all samples were very low
nd required long exposure times for detection, but
PS injection into tumor-bearing mice increased NF-κB
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979Figure 1. Increased Tumor Development in IkkbDhep Mice
(A) Expression of IKKβ in hepatocytes (Hep) and nonparenchymal cells (nonpar) of 15-day-old IkkbDhep mice.
(B and C) Livers of 8-month-old DEN-treated male IkkbF/F (B) and IkkbDhep (C) mice. Arrows, neovascularization.
(D and E) Typical liver histology (2.5× magnification; H&E stain) in 8-month-old DEN-treated male IkkbF/F (D) and IkkbDhep (E) mice.
(F) Numbers of tumors (R0.5 mm) in livers of male IkkbF/F (n = 13) and IkkbDhep (n = 14) mice 8 months after DEN (5 mg/kg) injection.
(G) Fractions of tumor occupied area in the large lobe of the liver (mouse number and treatment as above).
(H) Maximum tumor sizes (diameters).
(I and J) Gross ([I], arrowhead) and histological ([J], 200× magnification) appearance of lung metastases in IkkbDhep mice.
(K) Survival curves of IkkbF/F (n = 16) and IkkbDhep (n = 19) mice injected with DEN (5 mg/kg) at 15 days of age (p = 0.006).
(L) Incidence of HCCs (R0.5 mm) in female IkkbF/F (n = 10) and IkkbDhep (n = 11) mice 8 months after DEN (5 mg/kg) injection. Results in (F)
and (H) are averages ±S.E. Asterisks, p < 0.05 by Student’s t test.
Cell
980Figure 2. Biochemical and Cellular Characteristics of HCCs
(A) Expression of IKK and NF-κB proteins in tumor (T) and nontumor (NT) tissues 8 months after DEN treatment. Lysates of microdissected
HCCs or nontumor liver tissue from untreated (C) or DEN-treated mice were gel separated and analyzed by immunoblotting with antibodies
to the indicated proteins.
(B) Expression of IKKβ in isolated HCC cells.
(C) HCCs were genotyped by PCR. F, floxed allele, , deleted allele.
(D) IKK activities (KA) were determined by immunecomplex (anti-IKKα) kinase assays of tumor lysates. F/F-C and F/F-LPS are lysates of
untreated and LPS-treated mouse liver, respectively, used as controls. Protein recovery was determined by immunoblotting with anti-IKKα an-
tibody.
(E) Expression of cell-cycle-associated proteins. The lysates described in (A) were gel separated and immunoblotted with antibodies to the
indicated proteins.
(F and G) Frequencies of proliferating (F) and apoptotic (G) cells in IkkbF/F (n = 10) and IkkbDhep (n = 10) HCCs determined by PCNA nuclear
staining or a TUNEL assay, respectively. Results are averages ±S.E. Asterisks, p < 0.05.activity in IkkbF/F tumors but not IkkbDhep tumors (Figure L
aS3). Consistent with these results, neither IkkbF/F nor
IkkbDhep tumors from untreated mice exhibited detecta- T
Ible IKK activity (Figure 2D).
i
cIkkbDhep Tumors Exhibit Increased Cellular Turnover
Cell-cycle regulators and tumor suppressors in tumor J
dand nontumor samples were also analyzed. PCNA,
cyclin D1, c-Jun, c-Myc, CDK2, and CDK1 were ele- a
svated in HCCs compared to nontumor tissues (Figure
2E). PCNA and c-Jun were slightly higher and c-Myc o
lwas vastly higher in IkkbDhep than IkkbF/F tumors (Figure
2E). No differences in p53 were detected between ge- s
inotypes or tumors versus normal tissue (Figure 2E).
IKKβ-deficient HCCs contained more proliferating cells m
athan IkkbF/F HCCs (Figure 2F) but also contained more
apoptotic cells (Figure 2G), indicating enhanced turnover. coss of IKK Augments Hepatocellular Death
nd Compensatory Proliferation
o reveal the basis for the increased susceptibility of
kkbDhep mice to chemical carcinogenesis, we exam-
ned early effects of DEN on signal transduction and
ell behavior. DEN administration activated IKK and
NK in livers of IkkbF/F mice (Figure 3A). Loss of IKKβ
iminished IKK activation but enhanced the magnitude
nd duration of JNK activation (Figure 3A and data not
hown). Immunohistochemistry revealed nuclear RelA
nly in nonparenchymal cells in DEN-treated IkkbDhep
iver, whereas both hepatocytes and nonhepatocytes
howed nuclear RelA in IkkbF/F liver (Figure S4A). The
ncrease in JNK activity suggested that deletion of IKKβ
ay result in more DEN-induced cell death (Kamata et
l., 2005; Maeda et al., 2003). Indeed, appearance of
irculating liver enzymes (indicative of necrotic liver in-
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981jury) and TUNEL assays revealed more hepatocyte
death in centrilobular lesions in DEN-treated IkkbDhep
mice relative to similarly-treated IkkbF/F mice (Figures
3B, 3C, and 3E). Electron microscopy and histological
analysis revealed more apoptotic and necrotic cells af-
ter DEN administration in IkkbDhep than IkkbF/F mice
(Figure 3C and Figures S4B and S4C). It should be
noted, however, that only a fraction of the total hepato-
cytes undergoes cell death in response to a carcino-
genic dose of DEN, even in IkkbDhep mice.
Due to their high regenerative capacity, surviving he-
patocytes should undergo a compensatory proliferative
response. Bromodeoxyuridine (BrdU) labeling revealed
higher numbers of proliferating hepatocytes in IkkbDhep
than IkkbF/F mice after DEN exposure (Figures 3D and
3E). The proliferating cells were most common around
clusters of apoptotic cells in centrilobular lesions, con-
firming that DEN-induced cell loss triggers compensa-
tory hepatocyte proliferation. This response is aug-
mented in IkkbDhep mice.
TNFα is a potent inducer of liver cell death but is also
involved in liver regeneration (Fausto, 2000). As shown
below, TNFα mRNA was induced after DEN injection,
but no differences were observed between IkkbDhep and
IkkbF/F mice. To investigate the involvement of TNFα
in either DEN-induced cell death and/or compensatory
regeneration in IKKβ-deficient mice, IkkbDhep and
Tnfr1−/− mice were crossed, their progeny were given
DEN, and circulating liver enzymes were measured.
TNFR1 ablation reduced the amount of circulating liver
enzymes at 48 hr but not at 24 hr after DEN exposure by
approximately 50% (Figure 3F). IkkbDhep/Tnfr1−/− mice
exhibited an even greater reduction in the number of
proliferating hepatocytes at 48 hr after DEN exposure
relative to IkkbDhep mice (Figure 3G).
Prolonged JNK activation in NF-κB-deficient cells
contributes to TNFα-induced cell death (Kamata et al.,
2005; Maeda et al., 2003; Tang et al., 2001). To investi-
gate the role of JNK in the response to DEN, IkkbDhep
and Jnk1−/− mice were crossed, their progeny were in-
jected with DEN, and liver damage and compensatory
proliferation were assessed. JNK1 deficiency reduced
the amount of circulating liver enzymes at 48 hr after
DEN administration (Figure 3F), the extent of cell death
(data not shown), and the number of proliferating cells
(Figure 3G).
IkkbDhep Mice Exhibit Increased ROS Production
in Response to DEN
NF-κB, by controlling expression of Mn-superoxide dis-
mutase (MnSOD), a mitochondrial enzyme that detoxi-
fies superoxide anions, inhibits oxidative stress (Wong
and Goeddel, 1988). As expected, MnSOD but not
CuZnSOD (the cytoplasmic SOD) mRNA was decreased
in hepatocytes from untreated or DEN-treated IkkbDhep
mice (Figure 4A). Increased ROS accumulation follow-
ing TNFα stimulation causes prolonged JNK activation
in NF-κB- or IKKβ-deficient cells (Kamata et al., 2005;
Sakon et al., 2003). Accordingly, IkkbDhep mice display
increased oxidative stress after DEN administration.
The levels of reduced glutathione (GSH), a major cellu-
lar antioxidant, were much lower in the livers of DEN-
treated IkkbDhep mice than in similarly treated IkkbF/Fmice (Figure 4B). Conversely, DEN-induced lipid peroxi-
dation, assessed by malondialdehyde (MDA) and
4-hydroxyalkenals (HAE) content (Esterbauer and
Cheeseman, 1990), was substantially higher in IkkbDhep
than IkkbF/F mice (Figure 4C). To assess accumulation
of superoxide anions, we stained freshly frozen tissue
sections with dihydroethidine (Zhou et al., 2004). More
extensive staining in centrilobular lesions was seen af-
ter DEN administration in IkkbDhep than IkkbF/F mice
(Figure 4D). ROS production may cause oxidative DNA
damage, which can be detected with antibodies spe-
cific to 8-hydroxydeoxyguanosine (8-OHdG). One day
after DEN administration, livers of IkkbDhep mice exhib-
ited a much higher level of anti-8-OHdG reactivity than
IkkbF/F livers (Figure 4E).
Increased ROS production is a major contributor to
JNK activation and acute liver failure, both of which can
be prevented by feeding mice with the antioxidant bu-
tylated hydroxyanisole (BHA) (Kamata et al., 2005). To
investigate the role of ROS in the response to DEN,
mice were given BHA-containing (0.7%) or control
chow for 2 days and then challenged with DEN. As
found previously, consumption of BHA-containing diet
prevented the sustained phase of JNK activation in
IkkbDhep mice but had no effect on the initial response
(Figure 4F). Furthermore, BHA administration reduced
DEN-induced liver injury in IkkbDhep mice to a level sim-
ilar to that in IkkbF/F mice (Figure 4G). Histological
analysis revealed that BHA reduced both apoptosis and
necrosis (data not shown). Strikingly, BHA consumption
almost completely blocked compensatory proliferation
(Figure 4H) and appearance of 8-OHdG positive hepa-
tocytes (data not shown). Thus, loss of hepatocyte
IKKβ enhances DEN-induced cell death and compen-
satory proliferation through a mechanism likely to de-
pend on ROS accumulation.
BHA Consumption Decreases Hepatocarcinogenesis
in IkkbDhep Mice
If augmented ROS accumulation, the ensuing increases
in JNK activation, and compensatory hepatocyte prolif-
eration account for the elevated susceptibility of
IkkbDhep mice to DEN-induced hepatocarcinogenesis,
consumption of BHA around the time of DEN exposure
should reduce HCC development in these mice to the
level seen in IkkbF/F mice. To test this prediction, we
kept a cohort of IkkbDhep mice on normal diet, whereas
another cohort was fed a BHA-containing (0.7%) diet
for 4 days starting 2 days before DEN administration at
18 days of age (Figure 5A). Mice in both groups were
kept for 8 additional months on normal diet, after which
they were sacrificed and analyzed to determine tumor
load. Strikingly, the numbers of HCCs in BHA-fed
IkkbDhep mice were reduced 2.5-fold (Figure 5B). Tumor-
occupied areas and maximal tumor sizes were also re-
duced to levels similar to those in IkkbF/F mice (Figure
5C and data not shown).
To exclude the possibility that BHA prevents meta-
bolic activation of DEN or accelerates its detoxification,
we examined the expression of p53-regulated genes,
which provide an indirect measure of DEN-induced
DNA damage. We also examined expression of en-
zymes involved in DEN metabolism. No significant ef-
Cell
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983duced growth factor expression in Ikkb mice wasis the absence of IKKβ in Kupffer cells, where it may be
Figure 3. Loss of IKKβ Enhances both Cell Death and Compensatory Hepatocyte Proliferation after DEN Exposure
(A) Mice of indicated genotypes were injected with DEN and their livers isolated at indicated times and homogenized. IKK and JNK activities
were determined by immunecomplex kinase assays. Protein recovery was determined by immunoblotting with anti-IKKα and anti-JNK1 anti-
bodies.
(B) Mice were treated as above, and ALT levels in serum were determined when indicated.
(C and D) The extent of apoptosis (C) and cell proliferation (D) in livers of DEN-injected mice was determined by TUNEL staining or BrdU
labeling, respectively.
(E) Liver sections from untreated and DEN-injected mice were analyzed by indirect immunoperoxidase staining for BrdU (red)- and TUNEL
(green)-positive cells at the indicated times after DEN injection.
(F) ALT levels in mice of different genotypes were determined at indicated times after DEN injection.
(G) Frequencies of BrdU-positive proliferating cells at 48 hr after DEN injection. Results in (B)−(D) and (F) and (G) are averages ±S.E. Asterisks,
p < 0.05 by Student’s t test.fects of BHA on expression and induction of any of
these genes were observed (Figure 5D). BHA also did
not affect DEN-induced IKK activity (Figure S5). Thus,
a brief treatment with an antioxidant at the time of DEN
exposure prevented most of the elevated susceptibility
to DEN-induced liver carcinogenesis in IkkbDhep mice,
most likely via its ability to inhibit ROS accumulation.
Deletion of IKK in Hematopoietic-Derived
Cells Reduces Susceptibility
to DEN-Induced Carcinogenesis
The major cell type responsible for production of mito-
gens that stimulate compensatory hepatocyte prolifera-
tion during liver injury is the Kupffer cell, a type of mac-
rophage endogenous to the liver (Fausto, 2000). One
possible explanation for the difference between the re-
sults presented above and those reported by Pikarsky
et al. (2004), who found that inhibition of NF-κB de-
creases hepatocarcinogenesis, is that the IκB superre-
pressor used by these investigators to inhibit NF-κB
activation was also expressed in Kupffer cells. To test
this possibility, we wished to delete IKKβ in these cells.
Unfortunately, however, the LysM-Cre transgene, which
efficiently deletes the IkkbF allele in circulating and
bone-marrow-derived macrophages and neutrophils
(Greten et al., 2004), is not useful in Kupffer cells (Figure
S6). As an alternative approach, we crossed IkkbF/F
mice with Mx1-Cre transgenic mice, which express
CRE recombinase from the interferon-inducible Mx1
promoter. Injection of IkkbF/F:Mx1-Cre mice with poly(IC),
which induces interferon production, efficiently deletes
IKKβ in liver and spleen but not in most other tissues
(Figure 6A). In addition to macrophages (Hsu et al.,
2004), the Mx1-Cre mediated deletion is very effective
in B cells, Kupffer cells (Figure S6A), and hepatocytes
(hence the nearly complete absence of IKKβ in intact
liver). We therefore refer to these mice as IkkbDL+H, for
deletion in liver + hematopoietic cells. IkkbF/F:Mx1-Cre
and IkkbF/F mice were injected with poly(IC) on days 9,
11, and 13, followed by DEN injection at day 15. After
8 months, HCC development was analyzed. HCC load
was 4-fold lower in IkkbDL+H than in IkkbF/F mice (Figure
6B). Furthermore, the tumor-occupied area (data not
shown) and maximal tumor size (Figure 6C) were also
reduced in IkkbDL+H mice.
These results were completely opposite to those ob-
tained with IkkbDhep mice, in which IKKβ is missing only
in hepatocytes. One likely contributor to this differencerequired for induction of hepatomitogens such as TNFα
and IL-6 (Yamada et al., 1997). To examine this possi-
bility, we compared the effect of DEN on expression of
these factors in livers of IkkbF/F, IkkbDhep, and IkkbDL+H
mice. Whereas deletion of IKKβ only in hepatocytes did
not inhibit induction of any cytokine mRNA, deletion of
IKKβ in liver and hematopoietic cells attenuated induc-
tion of the mRNAs for TNFα (especially at the 4 hr time
point), IL-6, and HGF but had no effect on expression
of TGFα mRNA (Figure 7A). Furthermore, absence of
IKKβ solely from hepatocytes augmented expression
of TNFα, IL-6, and HGF mRNAs at the 24 hr time point,
most likely by increasing the extent of liver injury. Dele-
tion of IKKβ in macrophages and neutrophils but not in
Kupffer cells did not affect the induction of any of these
mRNAs (Figure S6B), underscoring the importance of
Kupffer cells rather than other myeloid cells for produc-
tion of hepatomitogens. To further establish the impor-
tance of Kupffer cells, IkkbDhep mice were treated with
gadolinium chloride (GdCl3), which selectively depletes
or inactivates Kupffer cells (Hardonk et al., 1992), 24 hr
before DEN injection. This resulted in diminished induc-
tion of TNFα (especially at the 24 hr time point), IL-6,
and HGF mRNAs but had no effect on TGFα mRNA
(Figure 7B). These results are similar to those found in
IkkbDL+H mice (Figure 7A). We isolated Kupffer cells
from DEN-injected IkkbDhep mice and measured mRNA
levels. Whereas TNFα and IL-6 mRNAs were abundant,
HGF and TGFα mRNAs were scarce (Figure S7A).
Immunohistochemistry confirmed that IL-6 is ex-
pressed mainly in Kupffer cells after DEN challenge of
IkkbF/F mice, but no IL-6 was detected in IkkbDL+H mice
(Figure 7C). Correspondingly, the proliferative response
to DEN was reduced in IkkbDL+H mice (Figure 7D) or
after GdCl3 treatment (Figure S7B). IkkbDL+H mice also
exhibited higher levels of liver injury and cell death
mostly at 24 hr after DEN administration relative to
IkkbF/F mice (Figure S8). This difference, however, was
smaller at 48 hr after DEN administration, suggesting
that liver injury at later stages might depend on an
IKKβ-mediated inflammatory response. Indeed, mice
lacking TNFR1 (Figure 3F) or IL-6 (Figure S9) exhibited
reduced liver injury but only at 48 hr after DEN injection.
Nonetheless, given the marked elevation in liver injury
seen in IkkbDL+H mice at 24 hr after DEN administration,
the reduction of the proliferative response (Figure 7D)
is quite remarkable and likely to account for the lower
susceptibility to DEN-induced carcinogenesis. Re-
DL+H
Cell
984Figure 4. Loss of IKKβ Enhances DEN-Induced Oxidative Stress
(A) RNA was isolated from IkkbF/F or IkkbDhep hepatocytes as indicated after DEN injection and Northern blotted for MnSOD, CuZnSOD, and
cyclophilin mRNAs.
(B) Liver lysates prepared at indicated times after DEN injection were analyzed for GSH content.
(C) Lipid peroxidation was examined at 0 and 24 hr after DEN injection by measuring malondialdehyde (MDA) in liver homogenates.
(D) Frozen liver sections prepared 24 hr after DEN or PBS (control) injection were stained with 2 M dihydroethidine hydrochloride for 30 min
at 37°C. Cells staining positively for the oxidized dye were identified by fluorescent microscopy.
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985Figure 5. Consumption of BHA-Containing Diet Prevents Aug-
mented Hepatocarcinogenesis in IkkbDhep Mice
(A) Outline of the experimental protocol. Mice were kept on either
regular or BHA-containing (0.7%) chow for 4 days, starting 2 days
before DEN (25 mg/kg) injection at postnatal day 18. On day 20,
mice were placed on normal diet and analyzed 8 months later.
(B and C) Numbers (B) and maximal sizes (C) of HCCs (R0.5 mm)
in livers of male IkkbDhep mice treated as indicated (n = 15 for each
group). Results are averages ±S.E. Asterisks, p < 0.05 by Student’s
t test.
(D) Mice (IkkbDhep) were treated with or without BHA for 48 hr before
DEN injection. Their livers were removed at 4 hr after DEN injection
for RNA extraction. Expression of the indicated genes was deter-
mined by real-time PCR. Results are averages ±S.E. (n = 3).2004). In the DEN model, however, an anticarcinogenicsults described above indicate that IKKβ, a major acti-
(E) Paraffin-embedded liver sections prepared 24 hr after DEN injection were immunostained with anti-8-OHdG antibody.
(F) IkkbDhep mice were fed either BHA-containing (0.7%) or regular chow for 2 days and then injected with DEN. JNK activity was determined
by immunecomplex kinase assay of liver lysates prepared when indicated after DEN injection.
(G) Mice were treated as above. After DEN injection (48 hr), ALT in serum was measured.
(H) IkkbDhep mice were treated as above or left untreated (−). Frequencies of BrdU-positive proliferating cells were determined 48 hr after DEN
injection. Results in (B), (C), (G), and (H) are averages ±S.E. Asterisks, p < 0.05 by Student’s t test.Figure 6. IkkbDL+H Mice Exhibit Lower Levels of DEN-Induced Hep-
atocarcinogenesis
(A) IKKβ is absent in livers of IkkbDL+H mice. Lysates from various
organs of 6-week-old IkkbF/F (−Cre) and IkkbF/F:Mx1-Cre (+Cre)
mice injected with poly(IC) were immunoblotted for IKKα and
IKKβ expression.
(B and C) Numbers (B) and maximal sizes (C) of HCCs (R0.5 mm)
in male IkkbF/F (n = 9) and IkkbDL+H (n = 9) mice 8 months after DEN
(5 mg/kg) injection. Results are averages ±S.E. Asterisks, p < 0.05
by Student’s t test.also seen after partial (70%) hepatectomy (Figure S10).
Correspondingly, the proliferative response after partial
hepatectomy was reduced in IkkbDL+H but not IkkbDhep
mice (Figure 7E).
Discussion
Although chemically induced hepatocarcinogenesis
was not expected to depend on inflammation, the re-vator of inflammatory processes, plays a key role in
DEN-induced hepatocarcinogenesis. Although IKKβ
was previously shown to be required for development
of CAC (Greten et al., 2004), its role in DEN-induced
hepatocarcinogenesis is different and more complex,
antitumorigenic in hepatocytes, the presumptive tumor
progenitors, and procarcinogenic in Kupffer cells,
which do not undergo malignant transformation. The
prototypic carcinogen used in this study, DEN, is me-
tabolized into an alkylating agent that induces DNA
damage and mutations (Verna et al., 1996) as well as
hepatocyte death (Farber and Gerson, 1984). As ex-
pected, loss of IKKβ in hepatocytes augments DEN-in-
duced death, but in this particular situation more cell
death potentiates, rather than attenuates, carcinogene-
sis. By contrast, in the CAC model, ablation of IKKβ
in enterocytes inhibits carcinogenesis by accelerating
apoptotic elimination of initiated cells (Greten et al.,
Cell
986Figure 7. IkkbDL+H Mice Express Lower Levels of Liver Growth Factors and Exhibit Decreased Compensatory Proliferation and a Model
(A) Mice of indicated genotypes were injected with DEN and at the indicated times liver RNA was extracted. The levels of various growth
factor mRNAs were determined by real-time PCR. Results are averages ±S.E. (n = 3).
(B) Mice were treated with or without GdCl3 24 hr before DEN administration at time = 0. The levels of growth factor mRNAs were determined
as above.
(C) Frozen liver sections were prepared at 0 or 12 hr after DEN injection and immunostained for IL-6 expression. IL-6-positive cells were also
positive for F4/80 (data not shown).
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987accumulation after DEN administration. Consumptionfinding that every HCC in Ikkb mice that was ana-
(D) Frequencies of proliferating cells in livers of indicated mice were determined by BrdU pulse labeling before and after DEN injection.
Results are averages ±S.E. Asterisks, p < 0.05 by Student’s t test.
(E) Mice of indicated genotypes were subjected to partial hepatectomy. Before each time point (2 hr) mice were injected with BrdU. When
indicated, liver sections were prepared and BrdU-positive cells were identified. Results are averages ±S.E. (n = 4 per each time point).
Asterisks, p < 0.05 by Student’s t test.
(F) A model explaining our results. The death of DEN-exposed hepatocytes, which is enhanced by an IKKβ deficiency, causes release of
cellular constituents that activate IKKβ and NF-κB in Kupffer cells to induce production of growth factors (IL-6, TNFα, HGF) that stimulate
proliferation of surviving hepatocytes harboring DEN-induced mutations.effect was achieved only when IKKβ was eliminated in
Kupffer cells and other types of myeloid cells, in addi-
tion to hepatocytes. As demonstrated, Kupffer cells are
critical for production of hepatomitogens. Unlike the
colon, which is subject to continuous renewal and thus
has a high cell turnover rate, the rate of cell turnover in
mature liver is extremely low and, without compensa-
tory proliferation, DEN-exposed hepatocytes do not
yield genetically transformed progeny. IKKβ plays a
critical role in this response by orchestrating oncogenic
crosstalk between dying hepatocytes and Kupffer cells
that is likely to depend on release of cellular constitu-
ents from the former that activate NF-κB in the latter,
where it induces expression of hepatomitogens that act
on surviving DEN-initiated hepatocytes (Figure 7F).
IKK and Chemical Hepatocarcinogenesis
Once activated by cytochrome P-450 enzymes, DEN
yields alkylating agents that modify DNA and induce
mutations (Verna et al., 1996). However, induction of
mutations is not sufficient for hepatocarcinogenesis. In
adult mice, due to its reduced toxicity (S.M., unpub-
lished data), DEN is a weak carcinogen that requires
assistance from tumor promoters. Some promoters,
such as carbon tetrachloride (Sarma et al., 1986) or ag-
onistic anti-Fas antibody (Hara et al., 2000), are cyto-
toxic. Others, such as phenobarbital and peroxisome
proliferators, act through various mechanisms, mostly
obscure, that eventually induce hepatocyte prolifera-
tion (Sarma et al., 1986). Our results provide strong ge-
netic support to the notion that critical for tumor pro-
motion is compensatory proliferation, causing initiated
hepatocytes to enter the cell cycle and transmit onco-
genic mutations to their progeny (Fausto, 1999). By fa-
cilitating hepatocyte killing, the loss of IKKβ results in
a paradoxical increase in DEN-induced hepatocarcino-
genesis. In other words, IKKβ is a tumor suppressor in
hepatocytes because it promotes their survival. A sim-
ilar effect was seen upon hepatocyte-specific overex-
pression of Bcl-2 (Pierce et al., 2002). Like IKKβ (Greten
et al., 2004), Bcl-2 is tumor promoting in other cell types
(Korsmeyer, 1992). Yet, in hepatocytes, Bcl-2 and IKKβ
suppress HCC by inhibiting compensatory proliferation.
Conversely, ablation of positive regulators of hepato-
cyte proliferation, c-Jun (Eferl et al., 2003) and Foxm1b
(Kalinichenko et al., 2004), inhibits hepatocarcino-
genesis.
Implicit to the conclusion that hepatocyte prolifera-
tion is essential to DEN-induced hepatocarcinogenesis
is the assumption that it is the mature hepatocyte that
is being transformed by DEN (Fausto, 1999; Fausto,
2000). This assumption is strongly supported by the
Dheplyzed was deleted for Ikkb. This deletion was caused
by CRE recombinase expressed from an albumin gene
promoter/enhancer that is specifically and strongly ac-
tivated in neonatal hepatocytes (Liao et al., 1980). Thus,
although it is formally possible that HCCs arise from
intrahepatic progenitors, such as oval cells (Sell and
Leffert, 1982), in which the albumin promoter had be-
come activated upon differentiation, this will delete Ikkb
only after acquisition of DEN-induced mutations. There-
fore, the most parsimonious interpretation of our results
is that DEN transforms differentiated hepatocytes, an
interpretation consistent with the strong correlation be-
tween hepatocyte proliferation in the different mouse
strains used in this study and HCC formation.
Hepatocyte proliferation in response to DEN expo-
sure depends on cytokine growth factors. Important
sources of these factors are Kupffer cells, which pro-
duce TNFα and IL-6 in an IKKβ-dependent manner. In-
terestingly, HGF is produced by stellate cells that are of
mesothelial origin rather than by Kupffer cells (Schir-
macher et al., 1993). Yet HGF production depends on
factors produced by Kupffer cells (Figure 7B). The role
of these mitogens in hepatocyte proliferation after par-
tial hepatectomy is well established (Fausto, 2000; Ya-
mada et al., 1997), and HGF is required for DEN-
induced hepatocarcinogenesis (Horiguchi et al., 2002).
Another growth factor involved in liver regeneration is
TGFα, whose overexpression promotes spontaneous
and DEN-induced HCCs (Fausto, 1999). Unlike TNFα,
IL-6, and HGF, TGFα expression is IKKβ independent
and takes place in hepatocytes (Fausto, 2000).
How does DEN induce expression of hepatocyte
growth factors? Although DEN is a relatively potent IKK
activator (Figure 3), it is unlikely that this effect is direct
or mediated through a specific receptor. Furthermore,
activation of IKK and NF-κB in response to DEN occurs
mainly in differentiated hepatocytes (Figure S4), whereas
the IKKβ-dependent mitogens are produced by other
cells. One likely mechanism may involve an inflamma-
tory signal transduction causing activation of Kupffer
cells by substances released by necrotic hepatocytes
such as HMGB1 (Scaffidi et al., 2002). Not surprisingly,
a supernatant of necrotic hepatocytes activates NF-κB
in primary macrophages (S.M., unpublished data).
Given the high rate of cell death in IkkbDhep tumors, this
response may occur even at later stages of the carcino-
genic process, resulting in constant supply of growth
and survival factors.
Role of ROS and Oxidative Stress
in Hepatocarcinogenesis
IkkbDhep mice exhibit elevated oxidative stress and ROS
Cell
988of an antioxidant for a short duration around the time d
fof DEN exposure reversed the elevation in HCC load
caused by loss of IKKβ. BHA also blocks prolonged N
aJNK activation and DEN-induced compensatory prolif-
eration but has no effect on JNK activation and com- (
cpensatory proliferation after partial hepatectomy (Ka-
mata et al., 2005), suggesting a considerable degree a
mof biological specificity. However, BHA can also induce
drug metabolizing enzymes through the Nrf2-depen- k
Adent antioxidant response (Kobayashi et al., 2004). Yet
Nrf2−/− mice, which fail to induce phase 2 enzymes, do t
anot show increased susceptibility to DEN-induced hep-
atocarcinogenesis (Satoh et al., 2002). Furthermore, a
dDEN, like other nitrosamines, is not detoxified by phase
2 conjugating enzymes (Williams, 1993). Indeed, BHA r
lconsumption had no effect on p53 and IKK activation
or the initial phase of DEN-induced JNK activation. v
7Given that JNK activity is required for liver regeneration
(Figure 3G), it is plausible that the major anticarcino- h
pgenic effect of BHA in IkkbDhep mice is due to inhibition
of prolonged JNK activation, which is ROS dependent v
((Kamata et al., 2005). Increased ROS accumulation was
also observed in mice with hepatocyte-specific c-Myc
hand TGFα transgenes (Thorgeirsson et al., 2000). Feed-
ing these mice with the antioxidant vitamin E decreased i
(ROS production, hepatocyte proliferation, and tumor
incidence (Factor et al., 2000). Although the mechanism e
Hby which vitamin E exerted its anticarcinogenic effect
was not explored, it was suggested that ROS generated o
vby TGFα signaling are the primary carcinogenic agents
in this model. While ROS can cause DNA damage, their l
aprimary tumor-promoting effect could be mediated
through JNK activation, the level and duration of which h
adetermine whether DEN-exposed hepatocytes will die
or proliferate, rather than direct induction of oncogenic i
mutations. Nonetheless, we cannot exclude the contri-
bution of oxidative DNA lesions to HCC development s
cin IkkbDhep mice.
H
tRole of Inflammation and Similarity
ato Other Models of Liver Cancer
jAlthough inflammation was not expected to be involved
fin chemical hepatocarcinogenesis, our results reveal
bthat inflammatory crosstalk between dying hepatocytes
rand myeloid cells is central to HCC development. One
olikely mechanism accounting for this crosstalk entails
dactivation of Kupffer cells by products released by dy-
κing hepatocytes, a well-established proinflammatory
umechanism (Scaffidi et al., 2002).
tRecently, inflammation-driven NF-κB activation was
shown to be instrumental in another model of liver car-
Ecinogenesis in which chronic hepatitis due to Mdr2 de-
ficiency plays a central role (Pikarsky et al., 2004). In A
that study, it was suggested that inhibition of NF-κB in J
hepatocytes, via Tet-induced IκB superrepressor trans- M
Lgene, decreases rather than increases tumorigenesis.
2Yet it should be noted that the C/EBPβ promoter used
fto express the Tet transactivator is not specific to hepa-
ttocytes and is active in myeloid and other cell types
N
(Akira et al., 1990; Talbot et al., 1994). Given the broader
specificity of this promoter, the results obtained by in- T
hibiting NF-κB in Mdr2−/− mice (Pikarsky et al., 2004) F
bare similar to the results we obtained with the Mx1-Cre-riven deletion of IKKβ in the DEN model. Thus, HCC
ormation in Mdr2−/− mice is also likely to depend on
F-κB activation in myeloid cells. Indeed, the survival
nd progression of HCCs in that model require TNFα
Pikarsky et al., 2004), a cytokine produced by Kupffer
ells and not hepatocytes. Similarly, adenovirus-medi-
ted delivery of catalytically inactive IKKβ to transgenic
ice expressing TGFα and c-Myc in hepatocytes led to
illing of already-developed HCCs (Cavin et al., 2004).
lthough it was assumed that the adenovirus delivered
he IKKβ mutant to hepatocytes, it should be noted that
denovirus more readily infects Kupffer cells (Lieber et
l., 1997). It is also noteworthy that inhibition of NF-κB
uring the first 7 months of life in Mdr2−/− mice did not
educe HCC formation (Pikarsky et al., 2004), most
ikely because it exerts opposing effects on tumor de-
elopment in hepatocytes and myeloid cells. Only after
months, when these mice exhibit full-blown chronic
epatitis due to activation of myeloid cells by dying he-
atocytes, does NF-κB inhibition decrease tumor de-
elopment. Thus, the results obtained by Pikarsky et al.
2004) may be consistent with our model (Figure 7F).
Another HCC model in which tumor development is
ighly dependent on inflammation is the HBsAg model,
n which the inflammatory response is T cell mediated
Chisari, 1995). Although NF-κB may be activated in liv-
rs of patients suffering from chronic viral hepatitis or
CC (Tai et al., 2000), this activation is probably sec-
ndary to the inflammatory response induced by the
irus, which drives expression of hepatomitogens. In
ight of our results, it is important to examine whether
n early effect of viral infection is inhibition of NF-κB in
epatocytes, which facilitates both hepatocyte death
nd inflammation-driven expression of hepatomitogens
n Kupffer cells.
Inhibition of NF-κB activation in keratinocytes also
timulates cell proliferation and promotes squamous
ell carcinoma (SCC) when combined with oncogenic
a-ras (Dajee et al., 2003). Interestingly, hyperprolifera-
ion of NF-κB-deficient keratinocytes depends on TNFα
s well as persistent JNK activation (Zhang et al., 2004),
ust as observed in DEN-treated IkkbDhep mice. Such
indings raise the specter that IKKβ inhibitors, currently
eing developed (Karin et al., 2004), may increase the
isk of HCC and SCC. However, the growth and survival
f both cancers requires production of NF-κB-depen-
ent cytokines by other cells. As pharmacological NF-
B inhibitors are unlikely to be cell type specific, their
se may not result in increased cancer incidence af-
er all.
xperimental Procedures
nimals
nk1−/−, IkkbF/F, IkkbF/F:Alb-Cre (referred to as IkkbDhep), and IkkbF/F:
x1-Cre (referred to as IkkbL+H after poly[IC] injection), IkkbF/F:
ysM-Cre (referred to as IkkbDmye) mice were described (Hsu et al.,
004; Maeda et al., 2003). Tnfr1−/− and IL-6−/− (C57BL/6) mice were
rom The Jackson Laboratory. All mice were maintained in filter
opped cages on autoclaved food and water at UCSD according to
IH guidelines.
umor Induction and Analysis
ifteen-day-old mice and littermates on a mixed C57BL/6/129
ackground (IkkbDhep and IkkbF/F mice were intercrossed at least
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989six times) were injected intraperitoneally (i.p.) with 5 or 25 mg/kg
DEN (Sigma), as indicated. For the initiation-promotion model,
4-week-old mice were injected i.p. with 100 mg/kg DEN and after
4 weeks received 0.07% phenobarbital (Sigma) in drinking water
for 6 months. When indicated, 16-day-old mice were given BHA-
containing (0.7%) or normal chow for 4 days. These mice were in-
jected with DEN (25 mg/kg) at day 18. After 8 months on normal
chow, all mice were sacrificed and their livers removed and sepa-
rated into individual lobes. Externally visible tumors (R0.5 mm)
were counted and measured by stereomicroscopy. Large lobes
were fixed in 4% paraformaldehyde overnight and paraffin embed-
ded. Sections (5 m) were H&E stained, and tumor-occupied areas
were measured using Scion Image for Windows. Remaining lobes
were microdissected into tumor and nontumor tissue and stored at
−80°C until analyzed. Apoptosis was determined by the ApoAlert
TUNEL Assay Kit (Clontech). To examine cell proliferation, mice
were injected i.p. with 100 mg/kg BrdU (Sigma) 2 hr prior to sacri-
fice, and paraffin sections were stained using the BrdU in situ de-
tection kit (Pharmingen). Liver injury was examined by measuring
circulating transaminases (Maeda et al., 2003).
Kupffer Cell Isolation and GdCl3 Treatment
Kupffer cells were isolated by collagenase digestion and dif-
ferential centrifugation using Percoll (Pharmacia). The liver was
perfused in situ as described (Maeda et al., 2003). The cell suspen-
sion was filtered through nylon gauze and the filtrate centrifuged
twice at 50 g for 1 min to remove hepatocytes. The nonparenchy-
mal cell fraction was washed with buffer and centrifuged through
a Percoll cushion at 1000 g for 15 min to obtain the Kupffer cell
fraction, followed by washing with buffer. Cells were plated in plas-
tic culture dishes and cultured for 1 hr, and nonadherent cells were
removed. Macrophages were cultured as described (Hsu et al., 2004).
To deplete Kupffer cells, mice were administered i.v. 10 mg
GdCl3-6H2O/kg (Sigma) or saline 24 hr before DEN administration
(Hardonk et al., 1992).
Biochemical and Immunohistochemical Analyses
IKK and JNK immunecomplex kinase assays, electrophoretic mo-
bility shift assays, immunoblotting, and immunohistochemistry
were described (Maeda et al., 2003). The following antibodies were
used: anti-IKKα (Imgenex); anti-IKKβ (Upstate); anti-IκBα, anti-c-
Myc, anti-cyclin D1, anti-p53, anti-CDK1, anti-CDK2, anti-RelA, and
c-Rel (Santa Cruz Biotechnology); anti-BrdU and anti-PCNA (Phar-
mingen); anti-8-OHdG (Japan Institute for the Control of Aging);
and anti-IL-6 (R&D). Analysis of mRNA expression by real-time PCR
or Northern blot analysis was described (Hsu et al., 2004; Maeda
et al., 2003).
GSH levels were measured as described (Kamata et al., 2005).
Lipid peroxidation was measured using an assay kit (Calbiochem)
that detects malondialdehyde (MDA) and 4-hydroxyalkenals (HAE),
which are generated by peroxidation of polyunsaturated fatty acids
and related esters. To assess levels of superoxide anions, freshly
prepared frozen sections were incubated with 2 M dihydroethid-
ine hydrochloride (Molecular Probes) for 30 min at 37°C, after which
they were observed by fluorescent microscopy and photographed.
Statistical Analysis
Data are expressed as means ±SEM. Differences were analyzed by
Student’s t test. P values %0.05 were considered significant. For
overall survival analysis, Kaplan-Meier curves were analyzed by log
rank test. In all cases, group size was chosen to produce results
that are statistically unambiguous.
Supplemental Data
Supplemental Data include ten figures and can be found with this
article online at http://www.cell.com/cgi/content/full/121/7/977/
DC1/.
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